Citation Tools
PDFBasic tumor immunology
Original research
Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival